Toulouse Onco Week 2025

1. Programme
2. Scientific programme
Scientific programme
Detailed scientific program
LEgend
- Keynotes & plenaries
- Coffee breaks & social events
- Companies technologies
- ISInvited speakers
- SCSelected communications
- person_pin Chairs
- interpreter_mode Presenting author

14:00 - 16:00 |Session 1: Artificial Intelligence & Cancer

Elisabeth MOYAL - INSERM DRTLS - DELEGATION REGIONALE OCCITANIE-PYRENEES, France

Vera PANCALDI - Cancer Research center of Toulouse, France

IS Cancer data infrastructures for computational analysis interpreter_mode Alfonso VALENCIA - Barcelona Supercomputing Center, Spain
SC Cellohood: Discovery of immunological cellular neighborhoods from protein markers in spatial tumor data interpreter_mode Marcin MOZEJKO - University of Warsaw, Warsaw, Poland visibility
IS Using AI to Enhance Care of Glioblastoma Patients interpreter_mode Ahmad BERJAOUI - Technological research institute Saint Exupéry, Toulouse, France visibility

16:00 - 17:00 |Coffee break and poster session 1

17:00 - 17:30 |Session 1: Artificial Intelligence & Cancer

IS AI in pathology: from bias mitigation to models interpretability interpreter_mode Camille FRANCHET - Oncopole Claudius Regaud, France
SC Dynamical modelling of gene regulatory networks in Chronic Lymphocytic Leukaemia: Understanding the role of immune cell interactions in cancer cell phenotypes interpreter_mode Malvina MARKU - Cancer Research Center of Toulouse, Toulouse, France visibility
IS Complex and simple Al/ML models for harnessing molecular data in oncology interpreter_mode Andrei ZINOVYEV - EVOTEC, Toulouse, France visibility

17:30 - 18:30 |Forecasting pancreatic carcinogenesis

person_pin

Elana FERTIG - Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, USA

18:30 - 20:30 |Ice breaking event

08:00 - 08:30 |Welcome coffee

08:30 - 09:45 |Session 2: Microenvironment and resistance

person_pin

Christine BEZOMBES - Cancer Research center of Toulouse, France

Catherine MULLER - Institute of Pharmacology and Structural Biology, France

Christine JEAN - Cancer Research center of Toulouse, France

IS The extracellular matrix: from proteomic exploration to matritherapies interpreter_mode Alexandra NABA - Department of Physiology and Biophysics, University of Illinois, Chicago, United States visibility
SC Tumour-stroma interactions in pancreatic cancer metastasis: Mechanisms and therapeutic opportunities interpreter_mode Ainhoa MIELGO - University of Liverpool, Liverpool, United Kingdom visibility
IS Tumor-associated myeloid cells: Harnessing integrins to disrupt their contribution to cancer progression interpreter_mode Frédéric LAGARRIGUE - Institute of Pharmacology and Structural Biology, Toulouse, France visibility

09:45 - 10:15 |Coffee break and poster session 2

10:15 - 12:10 |Session 2: Microenvironment and resistance

IS Harnessing gut immunity to target metastases interpreter_mode Christel DEVAUD - Cancer Research center of Toulouse, Toulouse, France visibility
SC Fibrinogen-like protein 2 (FGL2) is a multifaceted immune checkpoint with potential therapeutic application in B-cell non-Hodgkin Lymphomas interpreter_mode Juan GARCIA VALERO - Fundació de Recerca Clínic Barcelona, Barcelona, Spain - Centro de Investigación Biomédica en Red-Oncología, Madrid, Spain visibility
IS High endothelial venules (HEVs) : specialized blood vessels for lymphocyte entry in tumors during cancer immunotherapy interpreter_mode Jean-Philippe GIRARD - Institute of Pharmacology and Structural Biology, Toulouse, France visibility
IS Neural Switch in Pancreatic Cancer: From Early Defense to Tumor Support interpreter_mode Fanny MANN - Developmental Biology Institute of Marseille, Marseille, France visibility

12:10 - 13:00 |Companies and technologies pitches

13:00 - 14:30 |Lunch break - served on the exhibition area

14:30 - 15:45 |Session 3: Cancer therapeutic innovations

person_pin

Pierre CORDELIER - Cancer Research center of Toulouse, France

Julie GUILLERMET-GUIBERT - Cancer Research center of Toulouse, France

Julien MAZIERES - Toulouse University Hospital, France

IS Glutamine sensing in pancreatic cancer: from mechanisms of action to therapeutic perspectives interpreter_mode Myriam MARTINI - Molecular Biotechnology Center, Torino, Italy visibility
SC Furin silencing in T cells and repression by small molecule inhibitors reverses the exhausted phenotype of tumor-infiltrating T cells and enhances anti-tumor immunity interpreter_mode Majid KHATIB - Bordeaux Institute of Oncology, Bordeaux, France visibility
IS Oxaliplatin, ATR inhibitor and anti-PD1 combinaison leads to colon cancer eradication through immune system activation interpreter_mode Céline GONGORA - Montpellier Institute of Oncology, Montpellier, France visibility

15:45 - 16:15 |Coffee break and poster session 3

16:15 - 18:10 |Session 3: Cancer therapeutic innovations

IS Deciphering non-genetic tumor adaptation to prevent resistance to targeted therapies in oncogene-addicted lung cancer interpreter_mode Olivier CALVAYRAC - Cancer Research center of Toulouse, France
SC Ptch1 drug efflux inhibition: a promising strategy to overcome chemotherapy resistance of cancer cells interpreter_mode Isabelle MUS-VETEAU - Institute of Molecular and Cellular Pharmacology, Valbonne, France - University Côte d'Azur, Nice, France visibility
IS From PARP to targeting MTHFD1/2 for cancer specific folate trapping interpreter_mode Thomas HELLEDAY - Science for Life Laboratory, Department of Oncology-Pathology, Solna, Sweden visibility
IS Challenges in oncology: the Gustave Roussy perspective interpreter_mode Fabrice BARLESI - Gustave Roussy Institute, France

20:00 - 02:00 |Gala reception

08:00 - 08:30 |Welcome coffee

08:30 - 10:15 |Session 4 : Molecular mechanisms of resistance

person_pin

Kerstin BYSTRICKY - Center for Integrative Biology, France

Didier TROUCHE - Center for Integrative Biology, France

IS Defining mechanisms of genomic evolution in cancer interpreter_mode Sarah MCCLELLAND - Barts Cancer Institute, London, United Kingdom visibility
SC Advanced microscopy methods for the study of breast cancer interpreter_mode Lorenzo SCIPIONI - Cancer Research center of Toulouse, Toulouse, France visibility
IS Biomolecular condensates in nuclear organization interpreter_mode Fabian ERDEL - Center for Integrative Biology, Toulouse, France visibility
IS Impact of Arginine Citrullination on Transcriptional Control in Cancer interpreter_mode Priyanka SHARMA - Institute of Pharmacology and Structural Biology, Toulouse, France visibility

10:15 - 10:35 |Coffee break and poster session 4

10:35 - 12:10 |Session 4 : Molecular mechanisms of resistance

SC Impact of 5-Fluorouracil on cell plasticity interpreter_mode Laura JENTSCHEL - Institute of Functional Genomics, Montpellier, France visibility
IS Chromosome and chromatin dynamics during Transcription-coupled DSB repair interpreter_mode Gaëlle LEGUBE - Center for Integrative Biology, Toulouse, France visibility
IS Clonal Hematopoiesis in Cancer interpreter_mode Elsa BERNARD - Gustave Roussy Institute, Paris, France visibility

12:10 - 12:50 |Histone variants and their partners shaping chromatin and cell fate.

person_pin

Genevieve ALMOUZNI PETTINOTTI - Institut Curie, France

PCO agency - partner of the event :

INSIGHT OUTSIDE

contact@toulouse-onco-week.org
http://www.insight-outside.fr

Project holder :

GIP IUCT
1 Av. Irène Joliot-Curie
31100 Toulouse

http://www.iuct.fr

(*) Prices starting from fixed line incumbent, a surcharge may be applied by operators, counting the second after the first 45 seconds.

According to France's Personal Data Privacy Act in effect since June 2004, you may send a request in writing to INSIGHT OUTSIDE 26 Avenue Jean Kuntzmann 38330 Montbonnot-Saint-Martin / France, or by email webmaster@insight-outside.fr to access your file in order to consult, modify and/or delete your personal information.

© 2005 - 2025 Insight Outside

Organisation congrès scientifique Toulouse